113 related articles for article (PubMed ID: 1478681)
1. Hodgkin's disease cell lines: a model for interleukin-1-independent accessory cell function.
McKenzie JL; Egner W; Calder VL; Hart DN
Immunology; 1992 Nov; 77(3):345-53. PubMed ID: 1478681
[TBL] [Abstract][Full Text] [Related]
2. Human dendritic cells stimulate allogeneic T cells in the absence of IL-1.
McKenzie JL; Prickett TC; Hart DN
Immunology; 1989 Jul; 67(3):290-7. PubMed ID: 2527194
[TBL] [Abstract][Full Text] [Related]
3. Neoplastic cells obtained from Hodgkin's disease function as accessory cells for mitogen-induced human T cell proliferative responses.
Fisher RI; Bates SE; Bostick-Bruton F; Tuteja N; Diehl V
J Immunol; 1984 May; 132(5):2672-7. PubMed ID: 6609204
[TBL] [Abstract][Full Text] [Related]
4. Neoplastic cells obtained from Hodgkin's disease are potent stimulators of human primary mixed lymphocyte cultures.
Fisher RI; Bostick-Bruton F; Sauder DN; Scala G; Diehl V
J Immunol; 1983 Jun; 130(6):2666-70. PubMed ID: 6222113
[TBL] [Abstract][Full Text] [Related]
5. Production and characterization of a monoclonal antibody that binds Reed-Sternberg cells.
Hecht TT; Longo DL; Cossman J; Bolen JB; Hsu SM; Israel M; Fisher RI
J Immunol; 1985 Jun; 134(6):4231-6. PubMed ID: 3157756
[TBL] [Abstract][Full Text] [Related]
6. Identification of potent mixed leukocyte reaction-stimulatory cells in human bone marrow. Putative differentiation stage of human blood dendritic cells.
Egner W; McKenzie JL; Smith SM; Beard ME; Hart DN
J Immunol; 1993 Apr; 150(7):3043-53. PubMed ID: 8454872
[TBL] [Abstract][Full Text] [Related]
7. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
8. Gamma irradiation of human dendritic cells influences proliferation and cytokine profile of T cells in autologous mixed lymphocyte reaction.
Cao MD; Chen ZD; Xing Y
Cell Biol Int; 2004; 28(3):223-8. PubMed ID: 14984749
[TBL] [Abstract][Full Text] [Related]
9. Nodular sclerosing, mixed cellularity and lymphocyte-depleted variants of Hodgkin's disease are probable dendritic cell malignancies.
Kennedy IC; Hart DN; Colls BM; Nimmo JC; Willis DA; Angus HB
Clin Exp Immunol; 1989 Jun; 76(3):324-31. PubMed ID: 2787713
[TBL] [Abstract][Full Text] [Related]
10. Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step.
Morel AS; Quaratino S; Douek DC; Londei M
Eur J Immunol; 1997 Jan; 27(1):26-34. PubMed ID: 9021994
[TBL] [Abstract][Full Text] [Related]
11. B7/BB-1 is a leucocyte differentiation antigen on human dendritic cells induced by activation.
Hart DN; Starling GC; Calder VL; Fernando NS
Immunology; 1993 Aug; 79(4):616-20. PubMed ID: 8406586
[TBL] [Abstract][Full Text] [Related]
12. Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cells.
Plumas J; Chaperot L; Jacob MC; Molens JP; Giroux C; Sotto JJ; Bensa JC
Eur J Immunol; 1995 Dec; 25(12):3332-41. PubMed ID: 8566020
[TBL] [Abstract][Full Text] [Related]
13. Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells.
Gruss HJ; Brach MA; Drexler HG; Bonifer R; Mertelsmann RH; Herrmann F
Cancer Res; 1992 Jun; 52(12):3353-60. PubMed ID: 1596893
[TBL] [Abstract][Full Text] [Related]
14. Role of tumour necrosis factor-alpha in dendritic cell-mediated primary mixed leucocyte reactions.
McKenzie JL; Calder VL; Starling GC; Hart DN
Bone Marrow Transplant; 1995 Feb; 15(2):163-71. PubMed ID: 7773205
[TBL] [Abstract][Full Text] [Related]
15. Functional differences and complementation between dendritic cells and macrophages in T-cell activation.
Guidos C; Sinha AA; Lee KC
Immunology; 1987 Jul; 61(3):269-76. PubMed ID: 2956179
[TBL] [Abstract][Full Text] [Related]
16. Anti-leucocyte common (CD45) antibodies inhibit dendritic cell stimulation of CD4 and CD8 T-lymphocyte proliferation.
Prickett TC; Hart DN
Immunology; 1990 Feb; 69(2):250-6. PubMed ID: 1968425
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathways of adhesion in spontaneous rosetting of T-lymphocytes to the Hodgkin's cell line L428.
Sanders ME; Makgoba MW; Sussman EH; Luce GE; Cossman J; Shaw S
Cancer Res; 1988 Jan; 48(1):37-40. PubMed ID: 3275493
[TBL] [Abstract][Full Text] [Related]
18. Antigen presentation by Hodgkin's disease cells.
Fisher RI; Cossman J; Diehl V; Volkman DJ
J Immunol; 1985 Nov; 135(5):3568-71. PubMed ID: 3876389
[TBL] [Abstract][Full Text] [Related]
19. Retroviral interleukin-7 gene transfer into human dendritic cells enhances T cell activation.
Westermann J; Aicher A; Qin Z; Cayeux Z; Daemen K; Blankenstein T; Dörken B; Pezzutto A
Gene Ther; 1998 Feb; 5(2):264-71. PubMed ID: 9578847
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of antigen-independent and antigen-dependent interaction of dendritic cells with CD4+ T cells.
Hauss P; Selz F; Cavazzana-Calvo M; Fischer A
Eur J Immunol; 1995 Aug; 25(8):2285-94. PubMed ID: 7545116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]